Azelaic Acid Is the Most Underrated Ingredient for Brown Skin and Hyperpigmentation in India

Azelaic acid is a dicarboxylic acid that occurs naturally in grains like wheat, rye, and barley. Your skin already encounters trace amounts of it. At the 10 to 20% concentrations used in skincare formulations, it does three distinct things: it inhibits tyrosinase (the enzyme that triggers melanin overproduction), it kills the bacteria responsible for acne, and it reduces the abnormal skin cell growth that causes bumps and rough texture. These are not vague claims, the 20% prescription-strength formulation has been approved by the US FDA for rosacea and acne since the late 1990s, and the mechanism on tyrosinase inhibition is well-documented in dermatological literature, including a widely cited 2010 review in the Journal of Drugs in Dermatology by Breathnach et al.
What makes it unusual is that it does all three jobs without the photosensitivity risk that comes with retinoids, without the irritation ceiling of high-strength vitamin C, and without the purging phase that makes new users abandon actives. You can use it morning or night. You can use it while pregnant. For a category obsessed with dramatic before-and-after timelines, azelaic acid is almost aggressively undramatic, which is exactly why it gets ignored.Post-inflammatory hyperpigmentation is the mark a pimple, a rash, or a minor cut leaves behind long after the inflammation has cleared. On Indian skin and other brown skin tones, this mark can last months. Sometimes longer. The reason is that melanin-rich skin has more active melanocytes that are primed to respond to any injury signal by producing pigment. It's a protective response that overshoots.

Azelaic acid addresses this at the source. By blocking tyrosinase selectively in abnormally active melanocytes, it reduces pigmentation without affecting the surrounding skin's baseline tone. This selectivity matters. Hydroquinone, the older standard for hyperpigmentation, inhibits melanin production broadly and can cause ochronosis, a paradoxical darkening, with long-term use, particularly in darker skin tones. Azelaic acid does not carry that risk at standard concentrations. A 2004 study published in the International Journal of Dermatology found 20% azelaic acid comparable to 4% hydroquinone for melasma treatment, with a better tolerability profile.


For Indian skin specifically, this means azelaic acid can address the two most common concerns simultaneously: the active breakout and the dark mark it leaves behind. Most actives handle one or the other.Over-the-counter formulations in India typically run between 10% and 15%. Prescription-strength goes to 20%. For general hyperpigmentation and post-acne marks, 10% is a reasonable starting point. Results on pigmentation are slow, expect six to eight weeks before a visible difference, which is consistent with the skin's natural cell turnover cycle.


A few specifics that matter:


Apply it to clean, dry skin before heavier moisturisers. It absorbs better without a layer of product underneath. If you're using a retinoid at night, don't layer azelaic acid on top of it in the same routine, use one on alternate nights until your skin shows it can handle both. Sunscreen the next morning is non-negotiable, not because azelaic acid increases photosensitivity (it doesn't), but because UV exposure will undo the tyrosinase inhibition by triggering fresh melanin production.

The texture of most azelaic acid formulations is a lightweight gel or cream that sits well under makeup. It does not pill. It does not leave a white cast. These are practical advantages on brown skin that nobody in the marketing materials ever mentions.The Indian skincare market runs on three things: celebrity endorsement, dramatic before-and-after photography, and the promise of visible results within two weeks. Azelaic acid fails all three tests. It works slowly and quietly. The before-and-after difference at eight weeks is real but subtle enough that it won't photograph dramatically. And it's cheap to manufacture, which means the margin pressure to spend on marketing doesn't exist the way it does for, say, a vitamin C serum with a premium price point.

There's also a category problem. Azelaic acid sits awkwardly between acne treatment and brightening serum. Brands that sell acne products lead with salicylic acid or benzoyl peroxide because those show faster surface results. Brands that sell brightening serums lead with niacinamide or kojic acid because those have better name recognition. Azelaic acid gets shelved in neither category confidently.

The dermatologist community in India knows it well. It's a standard prescription for melasma, acne, and rosacea at most skin clinics. The gap is between what dermatologists prescribe and what the retail shelf offers, and that gap is almost entirely a marketing failure, not a formulation one.Prescription-strength 20% azelaic acid is available through dermatologists and compounding pharmacies in most metro cities. The brand Skinoren (20% cream) is the most commonly prescribed international formulation and is available at some pharmacies, though supply is inconsistent.

For over-the-counter options, a small number of Indian skincare brands now carry 10% formulations. The Ordinary's 10% Azelaic Acid Suspension is available through Nykaa and ships reliably. Minimalist, the Indian brand, offers a 10% azelaic acid serum that is widely available and reasonably priced. Both are straightforward, no-frills formulations without unnecessary fragrance or actives stacked on top, which is exactly what you want when you're introducing a new acid into a routine.

If you're dealing with active melasma or persistent hyperpigmentation that hasn't responded to over-the-counter options, the dermatologist route is faster. A prescription for 20% azelaic acid combined with sunscreen is a standard first-line treatment at most Indian skin clinics, and it costs considerably less than a course of chemical peels.

The ingredient that does the most for brown skin often comes in the plainest packaging, gets the least shelf space, and has no brand ambassador. That's not a coincidence, it's what happens when a useful, affordable compound enters a market built on selling aspiration. The skin doesn't care about the packaging. The tyrosinase doesn't respond to celebrity endorsement. What works on melanin-rich skin was always going to be found in a dermatologist's prescription pad before it made it to a Nykaa homepage.